CorpCast Episode 2: Advancement 101
CorpCast Episode 1: Sections, 204, 205 and In re Numoda
Are there drawbacks to positive thinking in legal transactions?
Homebuilder Series Webinar: Fiduciary Duties & Auditor Liability
FCPA Compliance and Ethics Report Episode 129-Judge Rakoff, Judge Leon and Individual Prosecutions Under the FCPA
Why Every Day Is Proxy Season for Public Companies
Do Employers Have to Pay For All Time Worked?
Do I need an attorney if I am buying or selling a business?
Corcoran: Infighting on Compensation Costs BigLaw Time and Money
Conducting Corporate Internal Investigations
Zimmermann: "Two Class" Partnership Culture Emerging in BigLaw
Appel: Corporate Inversions Could Mean Big Tax Bills For Shareholders
WORD OF THE DAY® for Hedge Funds – Accelerated Share Repurchase
Data Privacy: The Next Frontier of Corporate Compliance
Planning For The Exit – What’s Your Exit Strategy?
WORD OF THE DAY® for Hedge Funds – CFTC
What are the Implications of Alice v. CLS?
What Questions CEOs and Board Members Should Be Asking Themselves About Tax Inversions
WORD OF THE DAY® for Hedge Funds – Derivative
Legal Considerations for Web-Based Start-Ups
In the second video of a three-part series, Fenwick attorney Paul Smith talks about the growing anticipation surrounding this strong, conductive and flexible material.
Why the excitement? Simply put, graphene is easy. It’s...more
The technology and life sciences communities alike have been raving about new "wonder material" graphene for the past year. From applications for wearable devices to the creation of lightweight, bendable televisions and...more
The intense patent activity in graphene stems from its enormous technological and commercial potential. But because much of the territory underlying the graphene cross-roads has already been claimed, patenting graphene poses...more
In This Issue:
- DIGGING DEEPER: A Guide to Health Care Regulatory Due Diligence in Private Equity Deals 1
- Policy Spotlight: Affordable Care Act 6
- Case Spotlight: Best Practices in Down-Round Financings &...more
On August 22, 2012, the World Trade Organization welcomed Russia as its 156th member. As a result, Russia will lower its tariffs on imports of goods across all sectors of the economy and will reduce trade barriers. This will...more
The life science industry has had a long and mutually rewarding relationship with Harvard Medical School (HMS). HMS faculty members have founded life science companies, served as advisors and directors to life science...more
In any major license or partnering transaction, rarely is the royalty as simple as a single percentage on all net sales. The royalty provisions will include structures such as tier royalties, sublicense royalties, know-how...more
Life science companies are constantly entering into collaborations or other agreements with third parties in which new intellectual property may be created, whether it is a full-fledged partnership with a large pharmaceutical...more
Therefore, as may be seen, the two-stage patent opposition process has particularly affected the pharmaceutical industry, as the patent applicants are now vulnerable to multiple pre-grant oppositions filed by competitors, or...more
A patent is one of the ways by which technological innovations are protected. The most ironical fact about a patent is that although it gives monopoly for a number of years, but in order to gain the monopoly, the invention...more
IN THIS ISSUE:
..U.S. Supreme Court Addresses Manufacturer Price Discrimination
..Joint Venture Pricing Scrutinized
..Supreme Court Rules on Patent Tying
..Drug Companies Sued Over...more
Find a Business Organization Author »
Back to Top